We are live on ! Find out more
NMC

NEA Management Company Portfolio holdings

AUM $1.76B
1-Year Est. Return 223.33%
This Fund
S&P 500
This Quarter Est. Return
+24.51%
1 Year Est. Return
+223.33%
3 Year Est. Return
+769.45%
5 Year Est. Return
+668.45%
10 Year Est. Return
+14,843.34%
AUM
$1.93B
AUM Growth
-$596M
Cap. Flow
-$803M
Cap. Flow %
-41.67%
Top 10 Hldgs %
67.29%
Holding
46
New
–
Increased
6
Reduced
1
Closed
1

Top Buys

Rank Stock Value
1
MRSN
Mersana Therapeutics
MRSN
+$18.9M
2
NITE
Nightstar Therapeutics plc American Depositary Shares
NITE
+$8.84M
3
GNCA
Genocea Biosciences, Inc.
GNCA
+$6.15M
4
AUPH icon
Aurinia Pharmaceuticals
AUPH
+$2.42M
5
TRIL
Trillium Therapeutics Inc.
TRIL
+$1.04M

Top Sells

Rank Stock Value
1
TSRO
TESARO, Inc.
TSRO
+$774M
2
ESTC icon
Elastic
ESTC
+$66.1M

Sector Composition

Rank Sector Weight
1 Healthcare 73.01%
2 Technology 23.61%
3 Industrials 0.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SURF
26
DELISTED
Surface Oncology, Inc. Common Stock
SURF
$15.8M 0.82%
3,315,149
– –
CSBR icon
27
Champions Oncology
CSBR
$76.6M
$15.3M 0.79%
1,562,500
– –
LXRX icon
28
Lexicon Pharmaceuticals
LXRX
$1.06B
$13.2M 0.69%
2,382,286
– –
BE icon
29
Bloom Energy
BE
$69B
$12.2M 0.63%
1,333,333
– –
ARQL
30
DELISTED
Arqule Inc
ARQL
$12.1M 0.63%
2,520,316
– –
DZSI
31
DELISTED
DZS Inc. Common Stock
DZSI
$10.2M 0.53%
956,255
– –
RIGL icon
32
Rigel Pharmaceuticals
RIGL
$720M
$8.34M 0.43%
324,315
– –
VRNA
33
DELISTED
Verona Pharma
VRNA
$7.93M 0.41%
1,219,674
– –
KA
34
DELISTED
Kineta, Inc. Common Stock
KA
$7M 0.36%
39,691
– –
TRVN
35
DELISTED
Trevena, Inc.
TRVN
$5.95M 0.31%
6,099
– –
XFOR icon
36
X4 Pharmaceuticals
XFOR
$393M
$5.8M 0.3%
11,111
– –
TCON
37
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
$4.75M 0.25%
17,336
– –
PHXM
38
DELISTED
PHAXIAM Therapeutics S.A.. American Depositary Shares
PHXM
$4.74M 0.25%
62,500
– –
CTIC
39
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$3.64M 0.19%
3,750,000
– –
AKAO
40
DELISTED
Achaogen Inc
AKAO
$2.35M 0.12%
5,215,128
– –
ELGX
41
DELISTED
Endologix Inc
ELGX
$1.65M 0.09%
249,021
+1
+0% +$7
AKTX
42
Akari Therapeutics
AKTX
$13.1M
$1.62M 0.08%
565
– –
VIRX
43
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$1.58M 0.08%
37,094
– –
TRIL
44
DELISTED
Trillium Therapeutics Inc.
TRIL
$1.39M 0.07%
2,100,000
+850,000
+68% +$1.04M
RGLS
45
DELISTED
Regulus Therapeutics
RGLS
$934K 0.05%
91,575
– –
TSRO
46
DELISTED
TESARO, Inc.
TSRO
– –
-10,420,555
Closed -$774M
1
2

Similar funds

NM
NWI Management New York $1.76B AUM 45.08% 1-Year Est. Return
SLF
Sun Life Financial Toronto, Ontario, Canada $1.76B AUM 19.57% 1-Year Est. Return
SW
Simplicity Wealth Summit, New Jersey $1.76B AUM 20.49% 1-Year Est. Return
CGH
Contrarius Group Holdings Hamilton, Bermuda $1.77B AUM 83.15% 1-Year Est. Return
PWP
Principle Wealth Partners Madison, Connecticut $1.75B AUM 21.63% 1-Year Est. Return
CIP
CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return
GD
Grandfield & Dodd New York $1.77B AUM 23.43% 1-Year Est. Return
DF
DNCA Finance Paris, France $1.75B AUM 38.18% 1-Year Est. Return

NEA Management Company's Q1 2019 Portfolio in Review

As of Q1 2019, NEA Management Company held 46 positions worth $1.93B, down 24% from $2.52B the previous quarter. Its ten largest holdings account for 67% of the portfolio.

NEA Management Company withdrew a net $803M in Q1 2019, closing 1 position and reducing 1 holding. Its most notable exit was TESARO, Inc., an estimated $774M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 73% of assets, down from 80% a quarter earlier, followed by Technology and Industrials.

Against the trend, NEA Management Company added an estimated $18.9M to Mersana Therapeutics.

  • NEA Management Company added most to Mersana Therapeutics in Q1 2019, an estimated $18.9M increase.
  • NEA Management Company's biggest Q1 2019 reduction was Elastic, cutting an estimated $66.1M.
  • NEA Management Company fully exited TESARO, Inc. in Q1 2019, selling an estimated $774M.
  • NEA Management Company's ten largest holdings make up 67% of its $1.93B portfolio in Q1 2019.
  • NEA Management Company opened 0 new positions and closed 1 in Q1 2019.
  • NEA Management Company's portfolio value fell 24% quarter-over-quarter to $1.93B.

Based on NEA Management Company's 13F filing for Q1 2019, filed 8 May 2019.